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Inertial microfluidic systems have been arousing interest for medical applications 
due to their simple and cost-efficient use. However, comparably small sample 
volumes in the µl and ml range have so far prevented efficient applications in 
continuous bioprocesses. Nevertheless, recent studies suggest that these systems 
are well suited for cell separation in bioprocesses because of their facile 
adaptability to various reactor sizes and cell types. This review will discuss 
potential applications of inertial microfluidic cell separation systems in 
downstream bioprocesses and depict recent advances on inertial microfluidics for 
bioprocess intensification. The review thereby focusses on spiral microchannels 
that separate particles at a moderate Reynolds number in a laminar flow 
(Re<2300) according to their size by applying lateral hydrodynamic forces. Spiral 
microchannels have already been shown to be capable of replacing microfilters, 
extracting dead cells and debris in perfusion processes and removing contaminant 
microalgae species. Recent advances in parallelization made it possible to process 
media on a liter-scale which might pave the way towards industrial applications. 
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I. INTRODUCTION 
With more continuous bioprocesses being applied industrially, efficient cell separation 
methods are needed to retain productive cells in the system and thereby increasing process yield. 
However, currently used techniques like microfiltration and centrifugation show various 
drawbacks like membrane-clogging, low scalability and challenges in automatization. Since the 
introduction of first commercial cell-sorting FACS (fluorescence-activated cell sorting) systems, 
several chip-based microfluidic devices have been developed that offer cost-efficient solutions 
for separation and sorting of cells. They can be classified into active systems like 
acoustophoresis, magnetophoresis, dielectrophoresis and deterministic lateral displacement 
(DLD) that depend on external force fields, and passive systems that include gravitation- and 
inertia-based techniques. Passive systems are usually favored because of their lower complexity. 
Microfluidic separation techniques have been reviewed recently1–6 with some papers focusing on 
inertial devices in particular7–11. Inertial separation is solely based on channel geometry and 
hydrodynamic forces12 without requiring cell manipulation by external forces which makes it a 
robust and easy-to-use method. The most common architectures for inertial separation are 
straight and spiral microchannels. Straight microchannels are most commonly used for cell 
separation for medical purposes. Separation of circulating tumor cells13,14, red blood cells15,16 and 
MCF-7 cells16 could already be shown. Spiral channels stand out because they allow processing 
at higher flow rates of up to 1 l/min17 due to their large channel geometry. The here presented 
channel structures were fabricated in polydimethylsiloxane (PDMS) using soft-lithographic 
techniques or in poly(methyl methacrylate) (PMMA) using laser cutters. These materials can 
prospectively be combined with semiconductor manufacturing processes which opens the door 
for new lab-on-chip applications with elements from both microfluidics and microelectronics18. 
Medical applications of spiral microchannels today are manifold and include isolation of 
Th
is 
is 
the
 au
tho
r’s
 pe
er
 re
vie
we
d, 
ac
ce
pte
d m
an
us
cri
pt.
 H
ow
ev
er
, th
e o
nli
ne
 ve
rsi
on
 of
 re
co
rd
 w
ill 
be
 di
ffe
re
nt 
fro
m 
thi
s v
er
sio
n o
nc
e i
t h
as
 be
en
 co
py
ed
ite
d a
nd
 ty
pe
se
t.
PL
EA
SE
 C
IT
E 
TH
IS
 A
RT
IC
LE
 A
S 
DO
I: 
10
.10
63
/1.
51
25
26
4
3 
 
circulating tumor cells19,20, blood cells21,22 and sperm cells23, isolating axons from neuronal cell 
bodies24, cell-cycle synchronization25, and blood-plasma separation26. As channel dimensions 
match typical cell sizes, a variety of different cells like mammalian cells, yeast27 and even 
bacteria28 could be separated. The reproduction of large-scale processes on microfluidic devices, 
however, is a challenging task.29. Currently, applying microfluidics in microalgae processes 
shows promising results. A size dependent separation of microalgae cells with different lipid 
content using dielectrophoresis and platforms for growth and oil production analysis30,31 have 
already been developed. This paper reviews potential applications of microfluidic cell separation 
and sorting in bioprocesses, thereby focusing on spiral channels as they show the highest 
potential for implementation in large-scale processes due to their energy efficiency and facile 
scalability. 
A. Separation principle in spiral microchannels 
In spiral microchannels with a laminar Poiseuille flow, i.e. Reynolds numbers Re < 2300, 
three forces may cause a size-dependent separation. Shear gradient-induced (i) and wall-induced 
lift forces (ii) play important roles for separation in both straight and curved microchannels. 
Introducing curvature to the channel, however, induces a secondary-flow that accelerates the 
arrangement of particles in the equilibrium position. This is caused by a secondary-flow drag (iii) 
force, called Dean drag. 
The shear gradient-induced lift force is caused by the parabolic velocity profile in the channel 
that leads to different velocities on either side of the particle. The particle thereby experiences a 
force pushing it to areas with lesser relative velocity differences which can usually be found in 
the near-wall region.32 Thus, shear-gradient induced lift forces counteract wall-induced lift forces 
and particles in that fluid stream therefore arrange at positions in the channel where these forces 
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are in balance (Fig. 1). In rectangular channels two of these equilibrium positions can be 
identified. They preferably form close to the center of the channel’s side walls. The magnitude of 
both inertial lift forces depends on particle size and they become stronger at higher Reynolds 
numbers.8 The shear-gradient lift force FSG can be calculated from 
 
𝐹𝑆𝐺 =  
𝐶𝑆𝐺𝜌𝑈𝑀𝑎𝑥
2𝑎3
𝐷ℎ
, (1) 
where CSG is the lift coefficient for the shear gradient lift force, ρ is the fluid density, UMax is the 
fluid’s maximum velocity, a is the particle diameter and Dh is the hydraulic diameter that can be 
calculated for rectangular channels by 2h×w/(h+w) with h and w being height and width, 
respectively.32 This shows that FSG becomes larger with decreasing channel dimensions which 
shows the necessity of microstructures for efficient particle separation. 
Wall-induced lift forces result from pressure that is building up in between the particle and 
the wall. The particle is slowed down by interactions with the wall and a force is induced that 
directs particles away from the channel wall towards the channel’s center.32 The wall-induced lift 
force FWI can be calculated from 
 
𝐹𝑊𝐼 =  
𝐶𝑊𝐼𝜌𝑈𝑀𝑎𝑥
2𝑎6
𝐷ℎ
4 , (2) 
where CWI is the lift coefficient for the wall interaction force.32     
Dean flows are also a result of velocity differences within the channel. As fluid parcels in the 
channel center move faster compared to the near-wall region, these parcels are carried towards 
the outer wall by the fluid’s inertia, once a curvature is introduced to the channel. This leads to a 
recirculation of the parcels and thereby a secondary flow is induced in the shape of two counter-
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rotating vortices at the top and bottom surfaces of the channel (Fig. 1).32 The Dean flow is 
characterized by a dimensionless Dean number that is defined as 
 
𝐷𝑒 = 𝑅𝑒 (
𝐷ℎ
2𝑅
)
0.5
, (3) 
where Re is the Reynolds number and R is the average radius. Thus, smaller radii generate 
stronger secondary flows.8 This secondary flow imparts a drag force on particles that acts 
differently on particles with different sizes and thereby improves separation efficiency.33 The 
terminus “separation efficiency” is hereby used in a purely qualitative way for processes with 
two or more cell types that differ in size. It takes into account the purity of each outlet fraction 
and the cellular composition of the original medium as large differences in cellular abundance 
should also lead to a higher contamination of the smaller fraction at the outlet. Another important 
consideration is the difference in main cell size. As cell sizes vary a lot, an overlap in cell sizes 
between two different cell types will reduce the outlet fraction’s purity. Increasing flow rates 
strongly leads to the Dean-flow becoming the dominant force which rather causes dispersion of 
the particles than separation.12 The secondary-flow drag force FD can be calculated by 
 𝐹𝐷 = 6𝜋𝜇𝑎𝑈𝑆𝐹 , (4) 
where µ is the fluid viscosity and USF=1.8×10-4De1.63 is the velocity of the secondary-flow.32 
Guan et al.34  examined spiral microchannels with trapezoidal cross-sections and found that 
stronger Dean vortices were formed on the channel side with bigger depth which lead to an 
improved separation. 
Additionally to the three mentioned forces, several weak forces also act on the particles. 
These forces emerge when particles lead, lag or rotate in the fluid stream8 and are up to several 
orders of magnitude weaker than the above mentioned forces, which is why they can usually be 
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neglected.32 Rotational lift forces only get dominant after an initial equilibrium position is 
reached and help particles focusing near the channel walls’ center.12 Centrifugal effects play a 
minor role as the particles’ and fluid’s densities are too similar.10 
                                      
 
 
 
 
 
 
 
 
 
 
FIG. 1.  Major hydrodynamic effects affecting cell positioning in curved, rectangular microchannels. Wall-induced lift forces 
(FWI) push particles towards the channel’s center, whereas shear-induced lift forces (FSG) direct particles towards the side of the 
microchannel. By introducing curvature to the channel, a secondary flow is induced which applies a Dean drag (FD) on the 
particles that supports attaining equilibrium position. As all three hydrodynamic forces are size-dependent, differently sized cells 
focus at slightly different positions in the channel. 
 
II. APPLICATIONS OF SPIRAL MICROCHANNELS IN BIOPROCESSES 
A. Replacement of microfilters 
Microfiltration plays an important part in many industrial bioprocesses27 as particles ranging 
from 10 nm - 10 µm are difficult to separate from a suspension with other common methods like 
centrifugation, gravitational settling and adsorption techniques9 and biotechnologically relevant 
organisms typically range in that dimension. However, microfiltration is not flawless as 
membrane clogging and fouling occur frequently which drastically reduces efficiency of the 
method through e. g. retention of proteolytic enzymes from dead cells. Substitution of membrane T
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filters involves interrupting the process which increases risks of contamination and accounts for 
a major part of operating costs.27  
By increasing flow rates in their spiral microchannels slightly from 2 ml/min to 6 ml/min, 
Warkiani et al.27 could show that the device switches from a cell separation mode to a cell 
retention mode as all cells were focused at the inner wall. This allowed them to incorporate 
inertial microfluidics into a perfusion bioprocess. Cells where retrieved from the spiral’s inner 
outlet and lead back into the bioreactor for further protein production, whereas cell-free medium 
containing the produced protein and other small particles like cell debris was collected at the 
outer outlet and could be used for subsequent protein purification (Fig. 2). Replacing microfilters 
with spiral microfluidic devices has already been described35 in 2007 but recent advances show 
that inertial microfluidics can reach throughputs at least comparable to mechanical membrane 
filters which can process approximately 109 cells/ml.34 This is an essential requirement for 
industrial applications. 
Warkiani et al.27 could show cell retention for CHO and yeast cells, at the example of 
Saccharomyces cerevisiae, in separate approaches (Table I). CHO cell retention was first 
conducted with a single spiral at a flow rate of 6 ml/min and a retention efficiency of >95% 
could be measured for three different cell lines. They then went on to multiplex 84 microchips 
with four spirals each to retain CHO cells at a flow-rate of 500 ml/min. No change in viability, 
morphology and proliferation was observed and by measuring the expression of the shear stress 
biomarker c-Fos, it could be shown that no stress response could be detected in the cell which 
can probably be explained by the short residence time of only <0.1 s on the average within the 
spiral. Similarly to this approach, S. cerevisiae with a concentration of 105 cells/ml was retained 
at a lower flow rate of 2 ml/min based on smaller channel dimensions and cell sizes (3 -5 µm for 
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yeast compared to 10 – 20 µm for CHO cells).27 Yeast cells were retained with >90% efficiency 
in the single spiral and also in a multiplexed device with 180 spiral microchannels that could 
process 320 ml/min medium, which represents an improvement compared to commonly used 
cellulose acetate and teflon filters.27 
In a different experiment (Table I), Warkiani and co-workers could show that even cell-cycle 
synchronization is possible in spiral microchannels based on size differences in the stages of the 
cell-cycle. Cells in the G0/G1 phase were separated from G2/M-phase cells, which are generally 
larger in size, at a cell concentration of 106 cells/ml and a flow rate of 1 ml/min. After the 
separation process, smaller cells with diameters <14 µm were enriched more than 2.7 fold at the 
outer outlet. It would thereby be possible to retain only highly productive growing cells in the 
perfusion process. 
In 2017, Kwon et al.36 actually incorporated spiral microfluidic devices in perfusion 
processes for cell retention over a course of 18 – 25 days with peak CHO cell concentrations of 
20 - 30×106 cells/ml (Table I). In their first experiment, the process was run in a 350 ml 
bioreactor for 4 days in a batch mode with subsequent perfusion mode for another 14 days, 
applying a perfusion rate of two vessel volumes per day. The goal of the process was IgG1 
production. On day 10 the peak cell concentration of 22.7×106 cells/ml was reached with a cell 
viability of 99±1%. For cell concentrations <15×106 cells/ml, a retention efficiency of 99±2% 
could be achieved which dropped to 82±3% for cell concentrations in the range 20 -
23×106 cells/ml. Within 18 days, 263 mg IgG1 were be produced. 
Separately from the perfusion processes, Kwon and co-workers investigated cell retention 
efficiencies for even higher cell concentrations using increased channel dimensions 
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(1000×260/80 µm).36 At a flow rate of 4 ml/min, retention efficiencies of >84% could be reached 
for a CHO cell concentration of 43.6×106 cells/ml (Table I). 
 
 
 
 
 
 
 
 
 
 
 
FIG. 2.  General setup for cell retention with spiral, trapezoidal microchannels in perfusion bioprocesses. Medium from the 
bioreactor is pumped through the spiral at a specific flow rate where the dispersed cells (A) get focused at the channel’s inner 
wall by hydrodynamic effects (B). Cells then exit the spiral from the inner outlet and are lead back into the bioreactor while cell-
free medium is obtained from the spiral’s outer outlet and e. g. used for product recovery (C). 
 
 
This shows that inertial microfluidic devices can also be used for processes with high cell 
concentrations although they might probably not be applicable for current high-density processes 
with cell concentrations >100×106 cells/ml because of the small channel dimensions. By 
parallelizing the spirals, high throughputs may be generated which make inertial microfluidics 
more feasible for up-scaling to industrial processes. 
 
 
Th
is 
is 
the
 au
tho
r’s
 pe
er
 re
vie
we
d, 
ac
ce
pte
d m
an
us
cri
pt.
 H
ow
ev
er
, th
e o
nli
ne
 ve
rsi
on
 of
 re
co
rd
 w
ill 
be
 di
ffe
re
nt 
fro
m 
thi
s v
er
sio
n o
nc
e i
t h
as
 be
en
 co
py
ed
ite
d a
nd
 ty
pe
se
t.
PL
EA
SE
 C
IT
E 
TH
IS
 A
RT
IC
LE
 A
S 
DO
I: 
10
.10
63
/1.
51
25
26
4
10 
 
B. Separation of live and dead cells 
Removing nonviable cells and debris is often a crucial step in bioprocesses as dead cells can 
affect product yield by, for instance, releasing large amounts of proteases into the medium.37 
They can thereby also downgrade the product’s quality. In CHO bioprocesses, it could be shown 
that dead cells make up for up to 30% of the total produced biomass.38 Cell death in bioreactors 
is amongst others caused by apoptosis and also by shear stress through stirring and sparging in 
the reactor.37 Current methods for separation of dead cells include inclined settlers39 and more 
recently also compact settlers.40  
TABLE I. Overview of applied process parameters for presented applications of spiral microfluidic devices.  
Application 
Cell 
concentration 
[×106 cells/ml] 
Input flow 
rate 
[ml/min] 
Number 
of 
spirals 
Loops 
per 
spiral Particle 
Dimensions 
[µm] 
Separation/ 
retention 
efficiency 
[%] 
Refer- 
ence 
         
Cell retention 1.0 6.0a 4 n. a. CHO 80/130×600c >95 27 
Cell retention 10.0 500.0 336c n. a. CHO 80/130×600 n. a. 27 
Cell retention 0.1 2.0a 8 n. a. Yeast 30/70×450 90 27 
Cell retention 0.1 [g/l] 320.0 180c n. a. Yeast 30/70×450 >90 27 
Cell cycle 
synchronization 
1.0 1.0 1 n. a. CHO 80/130×600 n. a. 27 
Cell retention 4.8 1.0 1 8 CHO 80/130×600 99 36 
Cell retention 43.6 4.0 20c 6 CHO 260/80×1000 >84 36 
Live-dead cell 
separation 
3.5 1.5 1 8 CHO 80/130x600 99.7 41 
Live-dead cell 
separation 
10.0 8.0 2d 6/8 CHO 
80/130×600 
200/140×1000 
´99.9 41 
Live-dead cell 
separation 
4.0 6.0 4c 6 CHO 80/130×600 99.9 41 
Removal of 
contaminants 
0.3 – 6.3e 1.0 1 8 
Micro-
algae 
80/130×600 >90 12 
Parallelization n. a. 1000.0 20c 2.5 
Micro-
beads 
536×3000 88 17 
Cascading n. a. 
22.0 
12.0 
7.0 
3d 6 
Micro-
beads 
536×3000 
336×1800 
236×1200 
~95 
 
 
17 
        
a for a single spiral 
b heights of outer walls × width of channel’s base; microchannels with a trapezoidal cross-section were used except for the last two applications 
with microbeads where rectangular channels were used 
c parallelized spirals were used. 
d cascaded spirals were used. 
e P. tricornutum concentrations from 0.3 – 6 × 106 cells/ml and a fixed T. suecica concentration of 0.3 × 106 cells/ml were used. 
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Kwon et al.41  applied inertial microfluidics to separation of nonviable cells and cell debris 
from viable CHO cells. CHO cells are the most frequently used hosts for expression of 
recombinant proteins, accounting for more than 70% of the total worldwide recombinant 
proteins. Separation of the generally smaller dead cells in inertial microfluidic systems is 
difficult, because viable and nonviable cells overlap partly in size which sets a natural limit for 
the efficiency of the separation process.41 The size difference is caused by cell-shrinkage in the 
early stages of apoptosis which is important for regulating the activity of apoptotic nucleases and 
caspases.42 In their experiments41, Kwon and co-workers focused on maintaining high viable cell 
concentrations while concurrently removing as many dead cells as possible.  
In a first experiment (Table I), their system was tested for separation of cells <10 µm with 
3.5 × 106 cells/min, a flow rate of 1.5 ml/min and a split ratio of 0.36 which is defined as outer 
outlet flow rate divided by inner outlet flow rate. Dead cells and debris were focused at the outer 
outlet and a live cell retention efficiency of 99.7% was reached with a dead cell removal 
efficiency of 6.1%. They then proceeded to characterize their device by examining the 
correlation of cell concentration, flow rate, cell viability and flow split ratio on live cell retention 
efficiency, dead cell removal efficiency and dead cell removal purity which they defined as 
portion of nonviable cells in the outer outlet (Table II). Especially cell concentration seems to 
have a big impact on the separation process which can be explained by an increase of cell to cell 
interactions in the small microchannel with increasing cell concentration. In their final 
experiment, effects of cascading and parallelization on separation efficiency were investigated. 
For cascading, a wide spiral with six coils was connected to the already characterized narrow 
microchannel with 8 coils as a first stage of size-dependent separation (Table I). Flow rate could 
be increased to 8 ml/min and cell concentration was set to 10 × 106 cells/ml. This resulted in a 
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live cell retention efficiency of 99.9% while the dead cell removal efficiency dropped to 3.4%. In 
the parallel approach with four spirals (Table I) and inverted fluid flow at 4 × 106 cells/ml cell 
concentration and 6 ml/min flow through, the same live cell retention efficiency could be 
reached but dead cell removal efficiency dropped even further to 3%. However, even a small 
dead cell removal efficiency can have big impacts on bioprocesses as microfluidic systems can 
be run continuously. 
TABLE II. Effect of process parameters on separation measures, measured at cell concentrations from 1 - 10x106 cells/ml, flow 
rates from 0.9 - 1.5 ml/min, viabilities from 30 - 80% and flow split ratios from 0.32 - 0.85 in a spiral microfluidic device with 
eight loops, an inner depth of 80 µm, an outer depth of 130 µm and a width of 600 µm.41  
 Cell concentration
 Input flow rate Cell viability Flow split ratio 
Live cell retention efficiencya - 0 0 - 
Dead cell removal efficiencyb ++ + - ++ 
Dead cell removal purityc -- + - -d 
afraction of total viable cells in inner outlet. 
bfraction of total dead cells in outer outlet.  
cpurity of nonviable cells in outer outlet 
d0 means no correlation was observed; - means weak negative correlation; - - means strong negative correlation (separation measures change 
>10 % in measured range); + means weak positive correlation; ++means strong positive correlation (separation measures change >10 % in 
measured range) 
 
C. Removal of contaminants in microalgae cell cultures 
Microalgae cells are becoming more prominent in biotechnological processes, especially as 
source of biomass and production hosts for biofuels because of their ability to capture carbon 
dioxide.12 However, processes working with microalgae cells are especially susceptible to 
contaminations, primarily by zooplankton, phytoplankton-lytic bacteria, virus and other algae 
due to difficult sterilization processes.43 These cross-contaminations with other microalgae 
species are often inevitable. Resource competition and secretion of harmful secondary 
metabolites thereby leads to drastic decreases in process yield and product quality. Current 
methods to treat these contaminations include microfiltration, addition of chemicals acting 
against the pollutant and changes in environmental conditions like harsh changes in pH.43  
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In laboratory set-ups, time-consuming and labor-intensive techniques like serial dilutions and 
selective agar plates are usually applied to reduce contaminations. Syed et al.12 investigated the 
potential of inertia based microfluidic systems on separating the common invading microalgae 
Phaeodactylum tricornutum from a culture of Tetrasemis suecica cells. After tests with 6 µm and 
10 µm microbeads and microalgae cells, they found that the best separation was reached at a 
flow rate of 1 ml/min. The fusiform P. tricornutum with approximate diameters of 25.7 ±3.5 µm 
was focused at the outer outlet whereas T. suecica with a diameter of 10.7 ±0.8 µm exited 
through the inner outlet. Both cell types were focused with efficiencies >90%. In a second 
experiment (Table I), cell concentrations of P. tricornutum were gradually increased from 
0.3 × 106 cells/ml to 6 × 106 cells/ml while the T. suecica concentration was held at 
0.3 × 106 cells/ml to investigate the impact of pollutant concentration on the separation process. 
At all concentrations, P. tricornutum focusing efficiencies remained over 90% which 
demonstrates the insensitivity of the method to the contaminant’s concentration. After the 
separation, no measurable change in T. suecica vitality could be detected which distinguishes 
inertial microfluidic cell separation from other common methods for removal of contaminants. 
T. suecica was then reinoculated to test the sustainability of the purification process and it was 
found that P. tricornutum contamination remained suppressed until day 10 and at the end of the 
third week, contamination was still fifty times lower than in unpurified samples. By applying the 
separation process in a, for instance, two-week interval, P. tricornutum contamination could be 
suppressed. However, it was remarked that parallelization of the process is essential for 
upscaling to an industrial scale. 
Li and co-workers44 also worked on separating microalgae cells. They used straight 
microchannels to separate cells of the biodiesel producing alga Euglena gracilis based on 
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different shapes of the same organism to gain a shape-synchronized population. 105 cells/min 
could thereby be separated using five different outlets. In a different experiment by Condina et 
al.45, spiral microchannels were used to separate beer spoilage bacteria from yeast for subsequent 
identification using mass spectrometry. Separation efficiencies of >90% were reached at a flow 
rate of 1.5 ml/min. They could thereby improve the limit of detection for common contaminating 
bacteria in the beer industry and reduce the time for detection of contaminations. 
D. Bead-linked separation of specific cells and proteins 
For spiral microchannels, a confinement ratio of a/Dh > 0.07 was shown empirically, below 
which all particles flow through the outer outlet.46 From this follows that the minimal cell size 
that can be focused in spiral microfluidic devices is limited by the channel dimensions. Sarkar 
et al.47 developed a method that can evade this problem by linking cells to microbeads of 
different size with subsequent microfluidic separation. By binding specific cells to antibody-
coated microbeads (10 and 15 µm) with biotin-streptavidin linkages in a single binding step, they 
were even able to separate CD4+ from CD8+ T cells and T cells from B cells although these 
cells show only minimal differences in size (6 – 8 µm). For the latter approach, microbeads were 
coated with anti-CD3 and anti-CD19 antibodies, respectively. Their Dean Flow Fractionation 
Device (channel height was 115 µm) was thereby able to process around 105 beads/s. It could be 
observed that the focusing position in the channel was determined by the bigger part of the bead-
cell pair. In case microbeads and cells had the same size, an additive effect of the two sizes on 
focusing behavior was observed. In a different approach, Sarkar and co-workers separated three 
specific HIV-antibodies from total IgG-fractions of serum containing less than 1% antibodies 
that they targeted.47 Smaller microbeads with diameters of 10, 4.5 and 1 µm were used to 
improve surface to mass ratio which in turn improves antibody binding efficiency. 
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Approximately 95% of all three antigen-specific antibodies were purified with less than 5% 
cross-contaminations. 
The bead-linked separation approach could be used in the purification process of monoclonal 
antibodies and for separating small cells like bacteria which has only been done in few cases.48,28 
A cascaded setup could potentially even enable separation of a large number of different proteins 
or similar-sized cells. 
III. ADVANCES IN THROUGHPUT 
For most industrial processes, cell separation with flow rates in milliliter-scale, as shown by 
the previously mentioned applications, are insufficient. A single microchannel, however, can 
only process small flow rates while still maintaining efficient particle separation. Increasing flow 
rates in microfluidic devices can therefore only be done effectively by cascading or 
parallelization. Efficient upscaling of channel dimensions is restricted by the confinement ratio 
and as the biotechnologically relevant group of bacteria is very small (about 1×3 µm for 
E. coli49), channel dimensions have to be kept small, too. Cascading has already been applied, 
e. g. for separation of cells from blood samples50,51 but the focus rather lying on reaching higher 
separation efficiency compared to single devices than increasing throughput. Parallelization is 
difficult because in-plane parallelization would occupy too much space and stacked systems 
suffer from differences in inlet pressure depending on the distance of the microchip to the pump.   
Since the flow rate is a constitutive factor for reaching wanted equilibrium positions, Miller 
et al.17 developed a modular manifold, enabling equal inlet pressure distribution on a stack of 20 
spiral microchannels with a toroidal channel design (Table I). This allowed them to separate 
microbeads with sizes of 45 and 250 µm at a flow rate of 1 l/min which excels previous 
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parallelization approaches of inertia-based devices significantly.27,48 They thereby focused ~88% 
of the large microbeads in the inner outlet while ~73% of the small particles exited the spiral 
through the outer outlet. 
In a cascaded approach (Table I), described in the same paper, Miller and co-workers used 
spirals of three different widths (500, 300, 200 µm) to separate microbeads reaching from 1 – 
300 µm. Cascading allowed them to successively remove larger particles down to the smallest 
microbeads. To increase recovery rates, two recirculations were performed per separation step. 
By using a spiral with a comparably large cross-sectional area first, higher flow rates can be 
applied. It was also shown empirically in their experiments that for large spirals (>300 µm), the 
minimum focusing size rather correlates with 0.021356×H1.33623 where H is the channel height. In 
this case, an initial flow rate of 22 ml/min was set which automatically decreased to 12 ml/min in 
the second spiral and 7 ml/min in the third spiral. In the 500 µm spiral, ~95% of particles 
>95 µm could be focused whereas in the 200 µm spiral, ~96% of particles >50 µm were 
separated. Increasing the number of recirculations could eventually increase separation 
efficiencies even further. 
However, it should be taken into account that most industrial bioprocesses are based on cell 
cultures with densities several orders of magnitude higher compared to the cell suspensions in 
the described experiments. Cell concentrations can easily exceed 107 – 108 cells/ml.52 This leads 
to a severe increase in cell-to-cell interactions and might subsequently lead to clogging of the 
microchannel. In recent work by Maloudi et al.53 particle separation in scaled-up microchannels 
(500/900x2000 µm) was examined. By increasing channel size at a constant throughput, cell-to-
cell interactions could be reduced. It was shown that increased channel dimensions clearly lower 
the inertia of flow but particle separation was still possible. Additionally it could be shown that 
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even a single-loop trapezoidal channel is able to separate particles sufficiently. Reducing the 
channel’s length could therefore be another possibility to decrease the risk of clogging without 
diminishing the device’s performance too heavily. The experiments53 were conducted using a 
suspension of microcarriers (100 µm diameter) and mesenchymal stem cells. As shown by 
Maloudi et al. in 201854, microcarriers can be separated from mesenchymal stem cells at a flow 
rate of 30 ml/min and with a total yield of 94% using spiral microchannels. This indicates that an 
increased throughput can not only benefit cell separation for industrial purposes but also medical 
applications. Different medically relevant cell types like aforesaid mesenchymal stem cells, 
circulating tumor cells19,20 and chondrocytes55 could thereby be separated even faster from cell 
mixtures. 
IV. CONCLUSIONS 
Inertial microfluidic systems could already be applied for several bioprocessing steps, 
including replacement of microfilters, live-dead cell separation, removal of contaminating 
microalgae species and separation of specific cells and proteins by linkage to differently sized 
beads. As applying inertial systems for bioprocesses was just introduced recently, it is expected 
that the presented methods will be severely improved in the next years. The flexibility and 
scalability of these systems also allows for application to entirely different processes. The most 
relevant issue currently is parallelization, which is essential for upscaling to industry size. As 
natural limits are set for the flow rate in a microchannel, cascading and parallelization are the 
only ways to increase throughput beyond 1 l/min while still maintaining efficient particle 
separation. Although parallelizing microchannels appears easy, pumps are needed, leading to 
high energy costs with increasing system size which might make these systems unfeasible for 
industrial scale processes. Risks of system failure are, however, minimized by a parallel setup. 
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These risks include primarily clogging of the microchannels through cell agglomeration. Inertial 
microfluidic systems still have to be adapted to some biotechnologically relevant organisms like 
fungi and bacteria. The bead-linked approach could help here to apply microfluidic separation 
processes to other protists of different size.  
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